Cargando…
Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method
Human papillomavirus (HPV) vaccines are safe and effective in preventing HPV infection and cervical precancers. Neutralizing antibodies are thought to be the primary mechanism of protection for HPV vaccines, although the exact level required for protection has not been identified. Three common serol...
Autores principales: | Toh, Zheng Quan, He, Laura, Chen, Catherine, Huang, Angela, Russell, Fiona M., Garland, Suzanne M., Reyburn, Rita, Ratu, Tupou, Tuivaga, Evelyn, Frazer, Ian H., Mulholland, E. Kim, Licciardi, Paul V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655971/ https://www.ncbi.nlm.nih.gov/pubmed/33193410 http://dx.doi.org/10.3389/fimmu.2020.585768 |
Ejemplares similares
-
Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji
por: Ratu, Felisita Tupou, et al.
Publicado: (2018) -
Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
por: Toh, Zheng Quan, et al.
Publicado: (2019) -
Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019) -
Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine
por: Toh, Zheng Quan, et al.
Publicado: (2018) -
Human Papillomavirus Vaccination After COVID-19
por: Toh, Zheng Quan, et al.
Publicado: (2021)